Tasigna

Name: Tasigna - MedsBase.com
SKU: Tasigna
Availability: OutOfStock

✅ Treats Chronic Myeloid Leukemia
✅ Inhibits Cancer Cell Growth
✅ Improves Survival Rates
✅ Oral Administration Convenience
✅ Fewer Side Effects

SKU: Tasigna Categories: Anti Cancer Medication, Category Overview, Chronic Conditions

Tasignamg Capsule is prescribed for treating chronic myeloid leukemia (a type of blood cancer). It’s specifically used for patients who haven’t responded to other leukemia medications or who cannot tolerate them due to adverse effects.

For optimal results, take Tasignamg Capsule on an empty stomach at the same time each day. Your physician will determine the appropriate dosage and frequency based on your specific condition, which may be adjusted periodically. Strict adherence to your doctor’s instructions is crucial, as improper use or overdose can lead to severe complications. While benefits may take weeks or months to manifest, continue treatment unless directed otherwise by your healthcare provider.

Common side effects include headache, nausea, abdominal discomfort, and skin rashes. Report severe diarrhea immediately and maintain proper hydration during therapy. This medication may lower blood cell counts, increasing infection risk. Regular monitoring through blood tests is essential to track cell counts, heart/liver function, uric acid levels, and blood glucose/lipid profiles.

Inform your doctor about any pre-existing heart, liver, or kidney conditions, or if you’re taking anti-infective medications. Disclose all concurrent medications as numerous drug interactions are possible. Contraindicated during pregnancy and breastfeeding. Both male and female patients must use reliable contraception throughout treatment.

THERAPEUTIC INDICATIONS

Chronic myeloid leukemia (CML)

CLINICAL BENEFITS

In Chronic Myeloid Leukemia Management

As a hematologic malignancy affecting blood-forming tissues, CML compromises immune function. Tasignamg Capsule exerts its therapeutic effect by inhibiting proliferation and inducing apoptosis of malignant cells. Given its potent cytotoxic properties, thorough risk-benefit evaluation with your oncologist is imperative. Maintain adequate hydration and abstain from alcohol during therapy.

ADVERSE EFFECTS

Most adverse reactions are transient and resolve with continued therapy as the body adapts. Consult your physician if symptoms persist or cause concern.

Frequently Reported Reactions

Cephalalgia (headache)
Emesis/nausea
Gastrointestinal discomfort
Cutaneous eruptions
Pruritus
Alopecia
Myalgia
Asthenia (fatigue)

ADMINISTRATION GUIDELINES

Administer exactly as prescribed. Tasignamg Capsule requires fasting conditions for optimal absorption.

PHARMACOLOGICAL ACTION

As a targeted antineoplastic agent, Tasignamg Capsule inhibits abnormal tyrosine kinase proteins that drive malignant cell proliferation, thereby arresting disease progression.

Important Notice:

This information is provided for educational purposes after rigorous medical review. It does not constitute professional medical advice nor replace clinical judgment. The content may not encompass all potential adverse effects, contraindications, or drug interactions. Always consult your treating physician regarding any health condition or medication. This resource aims to complement, not substitute, the essential doctor-patient relationship.

Strength	150 mg, 200 mg
Quantity	28 Capsule/s, 56 Capsule/s, 84 Capsule/s
Pharma Form	Capsule/s
Manufacturer	Novartis
Treatment	Anti Cancer
Generic Brand	Temozolomide